Benzoic Acid

Benzoic Acid

SCHEMBL238325

CC[N+](C)(CC)CC.O=C([O-])c1ccccc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.61
CA4 P22748 1/20 0.61
CES1 P23141 7/20 0.48
CES2 O00748 6/20 0.48
ALPL P05186 1/20 0.46
POLB P06746 1/20 0.46
ALPG P10696 1/20 0.46
MEN1 O00255 2/20 0.44
LMNA P02545 2/20 0.44
KMT2A Q03164 2/20 0.44
TSHR P16473 2/20 0.44
CYP2D6 P10635 1/20 0.44
TAS2R10 Q9NYW0 1/20 0.44
CHRM4 P08173 2/20 0.42
CHRM1 P11229 2/20 0.42
CHRM3 P20309 2/20 0.42
KDM4E B2RXH2 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL31683012 0.90 CA2 (0.64) CA2CA4CES1CES2ALPL
Benzoic Acid SCHEMBL31683168 0.89 CA2 (0.53) CA2CA4CES1CES2ALPL
Benzoic Acid SCHEMBL31683104 0.88 CA2 (0.61) CA2CA4CES1CES2ALPL
Isophthalic Acid SCHEMBL3412411 0.86 CA2 (0.43) CA2CA4CES1CES2ALPL
Tetrylammonium SCHEMBL112480 0.86 CA2 (0.64) CA2CA4CES1CES2MEN1
Benzoic Acid SCHEMBL108980 0.85 CA2 (0.76) CA2CA4CES1CES2POLB
Isophthalic Acid SCHEMBL3412414 0.84 NOS3 (0.46) CA2CA4KMT2AHPGDSMN1; SMN2
Benzoic Acid SCHEMBL9012680 0.83 TSHR (0.61) CA2CES1CES2MEN1LMNA
Benzoic Acid SCHEMBL158696 0.83 CA2 (0.80) CA2CA4CES1CES2POLB
Tetrylammonium SCHEMBL28390101 0.82 CA2 (0.59) CA2CA4CES1CES2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330311-B1 STORAGE STABLE 1K-POLYURETHANE-PREPREGS AND MOULDED ARTICLE MADE FROM SAME ON THE BASIS OF A POLYURETHANE COMPOSITION EVONIK OPERATIONS GMBH (DE) 2021-05-05 EP claimed
US-10633519-B2 Storage-stable polyurethane prepregs and mouldings produced therefrom composed of a polyurethane composition with liquid resin components EVONIK OPERATIONS GMBH (DE) 2020-04-28 US claimed
US-10626236-B2 Storage-stable one-component polyurethane prepregs and shaped bodies composed of polyurethane composition that have been produced therefrom EVONIK OPERATIONS GMBH (DE) 2020-04-21 US claimed
US-20180155515-A1 STORAGE-STABLE ONE-COMPONENT POLYURETHANE PREPREGS AND SHAPED BODIES COMPOSED OF POLYURETHANE COMPOSITION THAT HAVE BEEN PRODUCED THEREFROM EVONIK OPERATIONS GMBH (DE) 2018-06-07 US claimed
EP-3330311-A1 STORAGE STABLE 1K-POLYURETHANE-PREPREGS AND MOULDED ARTICLE MADE FROM SAME ON THE BASIS OF A POLYURETHANE COMPOSITION Evonik Degussa GmbH (DE) 2018-06-06 EP claimed
EP-2411439-B1 PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE EVONIK DEGUSSA GMBH (DE) 2016-11-16 EP claimed
EP-2188320-B1 DUAL CURE FORMULATIONS WITH COMPONENTS COMPRISING URETDIONE GROUPS EVONIK DEGUSSA GMBH (DE) 2014-05-14 EP claimed
US-20140087613-A1 STORAGE-STABLE POLYURETHANE PREPREGS AND MOULDINGS PRODUCED THEREFROM COMPOSED OF A POLYURETHANE COMPOSITION WITH LIQUID RESIN COMPONENTS EVONIK DEGUSSA GMBH (DE) 2014-03-27 US claimed
EP-2688934-A1 STORAGE-STABLE POLYURETHANE PREPREGS AND MOLDED PARTS PRODUCED THEREFROM MADE OF POLYURETHANE COMPOSITION HAVING LIQUID RESIN COMPONENTS Evonik Degussa GmbH (DE) 2014-01-29 EP claimed
US-8455090-B2 Prepegs and molded bodies produced thereof at low temperature EVONIK DEGUSSA GMBH (DE) 2013-06-04 US claimed
WO-2012130672-A1 STORAGE-STABLE POLYURETHANE PREPREGS AND MOLDED PARTS PRODUCED THEREFROM MADE OF POLYURETHANE COMPOSITION HAVING LIQUID RESIN COMPONENTS EVONIK DEGUSSA GMBH (DE) 2012-10-04 WO claimed
US-20120003890-A1 PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE EVONIK DEGUSSA GMBH (DE) 2012-01-05 US claimed
US-20100227942-A1 DUAL-CURE FORMULATIONS WITH COMPONENTS CONTAINING URETDIONE GROUPS EVONIK DEGUSSA GMBH (DE) 2010-09-09 US claimed
JP-8245493-A None JP disclosed
US-20260071095-A1 POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE FUJIMI INCORPORATED (JP) 2026-03-12 US disclosed
US-20250320381-A1 POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE FUJIMI INCORPORATED (JP) 2025-10-16 US disclosed
JP-H08245493-A COLD MOLTEN SALT MITSUBISHI CHEM CORP 1996-09-24 JP disclosed
EP-0543311-B1 Electrolytic solution for electrolytic capacitor NIPPON CHEMICON (JP) 1995-06-28 EP disclosed
US-5338472-A Mixture of g-butyrolactone and ethylene glycol with quaternary alkylammonium phthalate, maleate or benzoate as solute, also with colloidal silica NIPPON CHEMI-CON CORPORATION (JP) 1994-08-16 US disclosed
EP-0543311-A2 Electrolytic solution for electrolytic capacitor NIPPON CHEMI-CON CORPORATION (JP) 1993-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071095-A1 POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE PIEZO1, ZAP70, CAPN1 CA2 695/4885CA4 634/4885CES1 3671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.